Cutaneous amyloidosis;Amyloses cutanées

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 1, 2005, Pages 62-70

  Modiano, P ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^b Centre Hospitalier Saint Philibert GHICL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; ANTIHISTAMINIC AGENT; APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; CALCIPOTRIOL; CORTICOSTEROID; DIMETHYL SULFOXIDE; IMMUNOGLOBULIN; MELPHALAN; PREDNISONE; PROTEIN PRECURSOR;

ALOPECIA; AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CHRONIC INFLAMMATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; ECCHYMOSIS; ELECTRON MICROSCOPY; EXPERIMENT; EXTRACELLULAR MATRIX; FAMILIAL DISEASE; GENETIC ANALYSIS; HEMODIALYSIS; HUMAN; KERATINOCYTE; LOW LEVEL LASER THERAPY; MOLECULAR BIOLOGY; MUTATION; ONYCHOMYCOSIS; PAPULE; PATHOGENESIS; POIKILODERMA; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PURPURA; RASH; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SEX DIFFERENCE; SKIN AMYLOIDOSIS; SKIN BIOPSY; SKIN INFILTRATE; STRUCTURE ANALYSIS; SYSTEMIC DISEASE; TISSUE;

EID: 14044276279     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(05)79203-6     Document Type: Article

References (47)

1. Cohen AS, Calkins E. Electron microscopie observation on a fibrous component in amyloid of diverse origin. Nature 1959;183:1202-3.
2. Glenner GG. Amyloid deposits and amyloidosis. The betafibrilloses I. N Engl J Med 1980;302:1283-92.
3. Modiano P. Amyloses cutanées. Encycl Méd Chir, Dermatologie, 98-720-A-10, 2003,10 p.
4. Glenner GG. Amyloid deposits and amyloidosis. The betafibrilloses II. N Engl J Med 1980;302:1333-43.
5. Hazenberg BP, Van Rijswijk MH. Clinical and therapeutic aspects of AA amyloidosis. Bailleres Clin Rheumatol 1994;8:661-90.
6. Benditt EP, Eriksen N. Chemical similarity among amyloid substances associated with longstanding inflammation. Lab Invest 1972;26:615-25.
7. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T et al. A new form of amyloid protein associated in the hemodialysis was identified as beta-2 microglobulin. Biochem Biophys Res Comm 1985;29:701-6.
8. Nichols WC, Dwulet FE, Liepnieks J, Benson MD. Variant apolipoprotein A1 as a major constituent of a human hereditary amyloid. Biochem Biophys Res Comm 1988;156:762-8.
9. Grateau G. Amyloses. In : Maladies et syndromes systémiques. Paris : Flammarion Médecine-Sciences, 2000:1279-308.
10. Wong CK. Mucocutaneous manifestations in systemic amyloidosis. Clin Dermatol 1990;8:7-12.
11. Bachmeyer C, Aractingi S. Les amyloses cutanées. Ann Dermatol Venereol 2000;127:1105-9.
12. Goltz RW. Systematized amyloidosis. A review of the skin and mucous membrane lesions and a report of two cases. Medicine 1952;31:381-409.
13. Vecchietti G, Masouye I, Salomon D, Dozier C, Saurat JH, Helg C et al. An unusual form of primary systemic amyloidosis: amyloid elastosis: report of a case treated by haematopoietic cell transplantation. Br J Dermatol 2003;148:154-9.
14. Buezo GF, Porras JI, Fraga J, Sanchez E, Aragues M, Dauden E. Coexistence of diffuse plane normolipaemic xanthoma and amyloidosis in a patient with monoclonal gammopathy. Br J Dermatol 1996;135:460-2.
15. Niemi K-M, Anton-Lamprecht I, Virtanen I, Suomalainen RJ Somer T, Linke RP. Fibrillar protein deposits with tubular substructure in a systemic disease beginning as cutis laxa. Arch Dermatol 1993;129:757-62.
16. Sepp N, Pichler E, Breathnach SM, Fritsch P, Hintner H. Amyloid elastosis: analysis of the role of amyloid P component. J Am Acad Dermatolol 1990;22:27-34.
17. Robert C, Aractingi S, Prost C, Verola O, Blanchet-Bardon C, Blanc F et al. Bullous amyloidosis. Report of 3 cases and review of the litterature. Medicine 1993;72:38-44.
18. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine 1975;54:271-99.
19. Mancuso G, Fanti PA, Berdondini RM. Nail changes as the only skin abnormality in myeloma-associated systemic amyloidosis. Br J Dermatolol 1997;137:471-2.
20. Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988;18:1-16.
21. Kuczynski A, Evans RJ, Mitchinson MJ. Sicca syndrome due to primary amyloidosis Br Med J 1971;2:506.
22. Hagari Y, Mihara M, Hagari S. Nodular localized cutaneous amyloidosis: detection of monoclonality of infiltrating plasma cells by polymerase chain reaction. Br J Dermatol 1996;135:630-3.
23. Grünewald K, Sepp N, Weyrer K, Lhotta K, Feichtinger H, Konwalinka G et al. Gene rearrangement studies in the diagnosis of primary systemic and nodular primary localized cutanenous amyloidosis. J Invest Dermatol 1991; 97:693-6.
24. Göttron HA. Amyloidosis cutis nodularis atrophicans diabetica. Dtsch Med Wochenschr 1950:75:19-24.
25. Borrowman TA, Lutz ME, Walsh JS. Cutaneous nodular amyloidosis masquerading as a foot callus. J Am Acad Dermatol 2003;49: 307-10.
26. Northcutt AD, Vanover MJ. Nodular cutaneous amyloidosis involving the vulva. Case report and literature review. Arch Dermatol 1985;121:518-21.
27. Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis. Review and long-term follow-up of 16 cases. Arch Dermatol 2003;139:1157-9.
28. Libbey CA, Skinner M, Cohen AS. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med 1993;143:1549-2.
29. Westermark P. Diagnosing amyloidosis. Scand J Rheumatol 1995;24:327-9.
30. Shimizu S, Yasui C, Yasukawa K, Nakamura H, Shimizu H, Tsuchiya K. Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity? Br J Dermatol 2003;149:400-4.
31. Sato KC, Kumakiri M, Koizumi H, Ando M, Ohkawara A, Fujioka Y et al. Lichenoid skin lesions as a sign of beta 2-microglobulin induced amyloidosis in a long-term haemodialysis patient. Br J Dermatol 1993;128:686-9.
32. Yoneda K, Watanabe H, Yanagihara M, Mori S. Immunohistochemical staining properties of amyloids with anti-keratin antibodies using formalin-fixed, paraffin-embedded sections. J Cutan Pathol 1983;16:133-6.
33. Ortiz-Romero PL, Ballestin-Carcavilla C, Lopez-Estebaranz JL, Iglesia-Diez L. Clinicopathologic and immunohistochemical studies on lichen amyloidosis and macular amyloidosis. Arch Dermatol 1994;130:1559-60.
34. Eto H, Hashimoto K, Kobayashi H, Fukaya T, Matsumoto M, Sun TT. Differential staining of cytoid bodies and skin-limited amyloidosis with monoclonal anti-keratin antibodies. Am J Pathol 1984;16:473-81.
35. Wang WJ. Clinical features of cutaneous amyloidoses. Clin Dermatol 1990;8:13-9.
36. Brownstein MH, Helwig EB. Cutaneous amyloidosis. I. Localized forms. Arch Dermatol 1970;102:8-19.
37. Brownstein MH, Helwing EB. Cutaneous amyloidosis. II. Systemic forms. Arch Dermatol 1970;102:20-8.
38. Wang W-J, Huang C-Y, Chang G Y-T, Wong C-K. Anosacral cutaneous amyloidosis: a study of 10 Chinese cases. Br J Dermatol 2000; 143:1266-69.
39. Yanagihara M, Mori S. Ano-sacral cutaneous amyloidosis. J Dermatol 1981;91:463-71.
40. Ogino A, Tanaka S. Poikiloderma-like cutaneous amyloidosis. Report of a case and review of the literature. Dermatologica 1977;155:301-9.
41. Roux ME, Grateau G. Les amyloses cutanées familiales. Ann Dermatol Vénéréol 1993;120:151-6.
42. Hamidi ASE L, Liepnieks JJ, Hamidi ASE K, Uemichi T, Moulin G, Desjoyaux E et al. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999;154:221-7.
43. Muckle TJ, Wells M. Urticaria, deafness and amyloidosis: a new heredo-familial syndrome. Q J Med 1962;31:235-48.
44. Wong CK. Treatment of cutaneous amyloidosis. Clin Dermatolol 1990;8:108-1.
45. Ozkaya-Bayazit E, Kavak A, Gungor H, Ozarmagan G. Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis. Int J Dermatol 1998;37:949-54.
46. Bonnetblanc JM, Catanzano G, Roux J. Dimethylsulfoxyde and macular amyloidosis Acta Derm Venereol 1980;60:91.
47. Khoo BP, Tay YK, Goh CL. Calcipotriol ointment vs. betamethasone 17-valerate ointment in the treatment of lichen amyloidosis. Int J Dermatol 1999;38:539-41.